Back to mobile site

More on PVLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/13/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Palvella Therapeutics (NQ:PVLA)
Delayed: 119.46 +6.36 (5.62%)
Prev. Close $113.10  
Open$115.29 
52 Wk High$ 
52 Wk Low$ 
Day High$120.88 
Day Low$114.55 
P/E N/A  
EPS$ 
Volume134,728 

Friends, Peers and Foes (?): PI6, BBIO, HRMY, 0ACX, ACLX (more...)

Jun 22, 2026 07:30 AM FDA grants rolling review for Palvella's rapamycin NDA for rare condition
Jun 22, 2026 07:30 AM FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
Jun 17, 2026 05:12 PM Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Jun 16, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 12 Filed by: Korenberg Matthew E
Jun 16, 2026 08:31 AM Form 8-K PALVELLA THERAPEUTICS, For: Jun 10
Jun 12, 2026 04:08 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: KIRITSY CHRISTOPHER P
Jun 12, 2026 04:08 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: JENKINS GEORGE M
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: HERON ELAINE J
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: Doux John
Jun 12, 2026 04:07 PM Form 4 PALVELLA THERAPEUTICS, For: Jun 10 Filed by: Davis Todd C
View All Articles

Entities mentioned with PVLA

View All Entities